Bath & Body Works, Inc. (BBWI) is a specialty retailer focused on personal care and home fragrance products. I reviewed six recent, individually attributable price targets: $20 from Piper Sandler, $22 from Morgan Stanley, UBS, and Telsey Advisory, $24 from TD Cowen, and $25 from Wells Fargo. Their average comes to roughly $22.50, which rounds to the $23 central target used here.
The tight $20-to-$25 cluster among these firms points to a generally cautious stance, with most ratings at "Hold" or "Equal Weight." Only TD Cowen and Wells Fargo carry "Buy" ratings, leading to an overall consensus of "Hold." Broader aggregator surveys show a much wider span from about $19 to $54 because a handful of more optimistic estimates are still in circulation. That spread reminds us the average is simply a midpoint amid differing opinions rather than a firm prediction.
Recent moves have been modest. Morgan Stanley lifted its target to $22 from $20, and UBS raised its to $22 from $19 in mid-November, while TD Cowen trimmed its to $24 from $25. These incremental shifts, not sweeping changes, define the current analyst picture. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The shares last closed near $18.91, with intraday levels around $19.17. Hitting the $23 target would mean roughly a 22% advance. Market capitalization stands at about $3.8 billion, and the trailing P/E ratio sits under 5, underscoring investor caution about growth prospects rather than any sign of distress.
Reaching the target would likely need signs that revenue can stabilize or return to growth. Quarterly revenue has been running in the $1.5 billion to $1.6 billion range, and the most recent quarter (reported November 19, 2026) delivered EPS of $0.26 and revenue of $1.58 billion, both above expectations. Continued beats like this, paired with solid holiday results, would offer the clearest path to higher analyst estimates.
A few factors stand out as potential supports. The valuation looks inexpensive with that low P/E and a dividend yield near 4.2%, which may draw income-focused investors during a turnaround period. The latest quarter beat expectations, which could encourage analysts to nudge targets upward over time. The company also holds a solid position in home fragrance and personal care, generating steady cash flow from its high-margin lineup.
If discretionary spending remains steady through the holidays and margins hold, the combination of attractive valuation and modest estimate revisions could allow for gradual multiple expansion toward the $20-to-$25 zone most analysts already reference.
The main challenge remains the revenue trajectory. Projections in recent years have pointed to flat or modestly declining sales, and Bath & Body Works depends heavily on physical store traffic. A softer holiday period, softer consumer spending, or heavier promotions could weigh on both top-line results and margins.
The prevalence of "Hold" ratings also reflects limited conviction on Wall Street. Multiples may stay compressed without a clear growth catalyst, and the broad analyst range—with some targets at or below the current price—shows that any re-rating is far from assured. A guidance cut or margin shortfall could quickly stall the modest momentum seen so far.
The stock has traded in a 52-week range of roughly $13.86 to $24.94. The $24-to-$25 zone marks notable resistance, aligning with both the 52-week high and several analyst targets. Support has appeared in the $17-to-$18 area recently, while the $20 level serves as a psychological hurdle the shares would need to clear and hold before a sustained push toward $23 looks realistic.
Analyst targets generally reflect a 12-month horizon, though exact periods vary. The key catalysts ahead include upcoming quarterly earnings and guidance, which often prompt target revisions, plus any holiday-season commentary on store traffic. Broader consumer discretionary trends, promotional activity in retail, and further analyst adjustments will also matter, given how frequent and occasionally mixed those changes have been for this name.
I have found Tickeron’s AI Daily Buy/Sell Signals helpful for tracking day-to-day momentum in names like BBWI. The tool applies artificial intelligence across thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on technical behavior and market conditions. For investors combining fundamental views with shorter-term signals, it offers a practical way to stay updated without constant manual screening.
Whether Bath & Body Works can reach $23 ultimately depends on its ability to stabilize revenue and persuade a cautious analyst community to raise estimates. The target represents the average of recent price targets clustered between $20 and $25, requiring about a 22% advance from current levels. Support comes from inexpensive valuation, a solid dividend, and a recent earnings beat, while obstacles include ongoing sales pressure, mostly "Hold" ratings, and a wide range of analyst views that includes targets below the current price. The outcome remains plausible if fundamentals improve, but it is not assured and will hinge on holiday results, guidance, and consumer spending trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The 10-day moving average for BBWI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in 194 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
BBWI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 85 of 145 cases where BBWI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The 10-day RSI Indicator for BBWI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 19 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBWI as a result. In 64 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for BBWI turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 36 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
BBWI moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.079) is normal, around the industry mean (2.178). P/E Ratio (5.606) is within average values for comparable stocks, (18.032). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (1.159). Dividend Yield (0.037) settles around the average of (0.102) among similar stocks. P/S Ratio (0.472) is also within normal values, averaging (1.080).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. BBWI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of retail business
Industry SpecialtyStores